This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Augmenting Selective Serotonin Reuptake Inhibitors With Clomipramine in Obsessive-Compulsive Disorder: Benefits and Risks, The Journal of Clinical Psychiatry, December 2013, Physicians Postgraduate Press, Inc,
DOI: 10.4088/jcp.13f08883.
You can read the full text:
The following have contributed to this page
